Insmed | INSM - Créanciers Commerciaux





Créanciers Commerciaux Changement Date
BioMarin Pharmaceutical USD 793.15M 34.12M 2026-03
Cytokinetics USD 24.71M 80.91M 2026-03
DBV Technologies USD 39.82M 972K 2025-09
Gilead Sciences USD 645M 70M 2026-03
Heron Therapeutics USD 8.99M 3.02M 2025-12
Insmed USD 73.38M 6.53M 2026-03
Novartis USD 4.46B 99M 2025-12
Regeneron Pharmaceuticals USD 1.03B 4.81B 2026-03
Sarepta Therapeutics USD 70.38M 210.46M 2026-03
Ultragenyx Pharmaceutical USD 42M 11M 2026-03
Vertex Pharmaceuticals USD 3.47B 40.6M 2026-03